JAC Advance Access originally published online on April 14, 2003
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Journal of Antimicrobial Chemotherapy (2003) 51, 1159-1165
© 2003 The British Society for Antimicrobial Chemotherapy
Enhancement of antibacterial and lipopolysaccharide binding activities of a human lactoferrin peptide fragment by the addition of acyl chain

Laboratory of Biotechnology, National Institute of Chemistry, Hajdrihova 19, SI-1000 Ljubljana, Slovenia
Received 22 October 2002; returned 13 December 2002; revised 17 February 2003; accepted 18 February 2003
Cationic antibacterial peptides are potentially therapeutic in the treatment of sepsis, because of their amalgamated antibacterial and lipopolysaccharide-binding activities. We prepared acyl analogues of the peptide fragment of human lactoferrin, which originally had weak antibacterial activity. It was found that 12 carbon units constitute the optimal acyl chain length, enhancing the antibacterial activity and binding of lipopolysaccharide by up to two orders of magnitude. Lactoferrin-based lipopeptides approached the activity of polymyxin B, a lipopeptide of natural origin, but were also active against Gram-positive bacteria.
Keywords: antibacterial peptide, endotoxin, human lactoferrin, lipopeptide
* Corresponding author. Tel: +386-1-476-0372; Fax: +386-1-476-0300; E-mail: roman.jerala{at}ki.si
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
G. N. Serrano, G. G. Zhanel, and F. Schweizer Antibacterial Activity of Ultrashort Cationic Lipo-{beta}-Peptides Antimicrob. Agents Chemother., May 1, 2009; 53(5): 2215 - 2217. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Rotem, I. S. Radzishevsky, D. Bourdetsky, S. Navon-Venezia, Y. Carmeli, and A. Mor Analogous oligo-acyl-lysines with distinct antibacterial mechanisms FASEB J, August 1, 2008; 22(8): 2652 - 2661. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. P. G. da Silva, D. Unks, S.-c. Lyu, J. Ma, R. Zbozien-Pacamaj, X. Chen, A. M. Krensky, and C. Clayberger In vitro and in vivo antimicrobial activity of granulysin-derived peptides against Vibrio cholerae J. Antimicrob. Chemother., May 1, 2008; 61(5): 1103 - 1109. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Rydlo, S. Rotem, and A. Mor Antibacterial Properties of Dermaseptin S4 Derivatives under Extreme Incubation Conditions Antimicrob. Agents Chemother., February 1, 2006; 50(2): 490 - 497. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Zorko, A. Majerle, D. Sarlah, M. M. Keber, B. Mohar, and R. Jerala Combination of Antimicrobial and Endotoxin-Neutralizing Activities of Novel Oleoylamines Antimicrob. Agents Chemother., June 1, 2005; 49(6): 2307 - 2313. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. S. Radzishevsky, S. Rotem, F. Zaknoon, L. Gaidukov, A. Dagan, and A. Mor Effects of Acyl versus Aminoacyl Conjugation on the Properties of Antimicrobial Peptides Antimicrob. Agents Chemother., June 1, 2005; 49(6): 2412 - 2420. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Japelj, P. Pristovsek, A. Majerle, and R. Jerala Structural Origin of Endotoxin Neutralization and Antimicrobial Activity of a Lactoferrin-based Peptide J. Biol. Chem., April 29, 2005; 280(17): 16955 - 16961. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Avrahami and Y. Shai A New Group of Antifungal and Antibacterial Lipopeptides Derived from Non-membrane Active Peptides Conjugated to Palmitic Acid J. Biol. Chem., March 26, 2004; 279(13): 12277 - 12285. [Abstract] [Full Text] [PDF] |
||||



